About Dr. Lal Pathlabs Franchise

As one of the top pathology labs in India, Dr Lal PathLabs has a very strong focus on hiring and retaining top quality manpower to drive our different departments within and outside the labs. Despite our size, we maintain an environment that nurtures some of the top thinkers in India in their respective fields of expertise.

Over 3000 individuals work at the Dr Lal PathLabs in India with over 55 percent of the staff in laboratory functions. We have a qualified team of 147 pathology specialists, 8 Radiologists, 13 Microbiologists, 5 Biochemists and 11 specialists with doctorate degrees. Also, there is a growing pool of young leadership from top institutions like AFMC, IIMs, IITs, XLRI, SP JAIN amongst others.

Franchise Products or Services

We focus on providing patients quality diagnostic healthcare services in India. Through our network, we offer patients convenient locations for their diagnostic laboratory services and efficient service. With over 5000+ diagnostic tests and related healthcare tests and services offered, we believe we are capable of performing substantially all of the diagnostic healthcare tests and services currently prescribed by physicians in India. By delivering most accurate reports over the years, Dr. Lal PathLabs has earned the reputation of being amongst the most trustworthy and reliable pathology labs in India.

Franchise Inclusions or Package

- Minimum investment around ₹ 3- 4 Lacs.

- Good Return On Investment.

- Exclusive DLPL Collection Center.

- Approx. 200-250 sq. ft. area at ground floor with toilet facility.

- Preferred from Medical experienced background.


Franchise Application Process


Franchise Contact Details

Phone/Mobile Number: +91 11 4988 5050

Emaill Address: [email protected]

Website: https://www.lalpathlabs.com/

Facebook Page: https://www.facebook.com/lalpathlabs

Franchise Business Address

Regd. Office: Block E, Sector -18, Rohini, New Delhi – 110085





This post is not yet verified by the owner.
Information and images are from the sources mentioned above.